Abstract
Benzodiazepines exhibit reversible, stereospecific high affinity binding to mammalian brain membranes, and the respective binding sites for 3H-flunitrazepam represent pharmacologically and clinically relevant receptors for benzodiazepines1–3. Recently it has been demonstrated that reversibly bound 3H-flunitrazepam becomes irreversibly attached to a specific membrane protein with apparent molecular weight of 50,000 when incubations were performed in the presence of UV light4,5. Irreversible binding of 3H-flunitrazepam to this protein had pharmacological properties similar to reversible benzodiazepine receptor binding, indicating that 3H-flunitrazepam is a photoaffinity label for the benzodiazepine receptor5. Using irreversible binding of 3H-flunitrazepam and subsequent electrophoretic separation of the labelled proteins in SDS-gels followed by fluorography6, we found that in hippocampus and several other brain regions at least two different types of benzodiazepine receptors exist. Each seems to be associated with a γ-aminobutyric acid (GABA) receptor.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Möhler, H. & Okada, T. Science 198, 849–851 (1977).
Squires, R. F. & Braestrup, C. Nature 266, 732–734 (1977).
Speth, R. C., Wastek, G. J., Johnson, P. C. & Yamamura, H. I. Life Sci. 22, 859–866 (1978).
Battersby, M. K., Richards, J. G. & Möhler, H. Eur. J. Pharmac. 57, 277–278 (1979).
Möhler, H., Battersby, M. K. & Richards, J. G. Proc. natn. Acad. Sci. U.S.A. 77, 1666–1670 (1980).
Laskey, R. A. & Mills, A. D. Eur. J. Biochem. 56, 335–341 (1975).
Braestrup, C. & Squires, R. F. Proc. natn. Acad. Sci. U.S.A. 74, 3805–3809 (1977).
Klepner, C. A., Lippa, A. S., Benson, D. I., Sano, M. C. & Beer, B. Pharmac. biochem. Behav. 11, 457–462 (1979).
Karobath, M. & Sperk, G. Proc. natn. Acad. Sci. U.S.A. 76, 1004–1006 (1979).
Krueger, B. K., Forn, J. & Greengard, P. J. biol. Chem. 252, 2647–2773 (1977).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sieghart, W., Karobath, M. Molecular heterogeneity of benzodiazepine receptors. Nature 286, 285–287 (1980). https://doi.org/10.1038/286285a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/286285a0
This article is cited by
-
GABAA – Rezeptorsubtypen: Strukturelle Vielfalt gibt Hoffnung auf neue Therapiekonzepte
Neuroforum (2015)
-
GABAA receptor subtypes: structural variety raises hope for new therapy concepts
e-Neuroforum (2015)
-
Analysis of γ-Aminobutyric Acid (GABA) Type A Receptor Subtypes Using Isosteric and Allosteric Ligands
Neurochemical Research (2014)
-
GABAA Receptors of Cerebellar Granule Cells in Culture: Interaction with Benzodiazepines
Neurochemical Research (2013)
-
Consequences of the Evolution of the GABAA Receptor Gene Family
Cellular and Molecular Neurobiology (2005)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.